{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-020272","form_type":"8-K","ticker":null,"cik":"0001522860","company_name":"Acutus Medical, Inc.","filed_at":"2024-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.812462+00:00","generated_at":"2026-06-02T23:08:04.584112+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Acutus Medical receives Nasdaq delisting notice; stock to suspend May 9","bullets":["Nasdaq notified Acutus Medical of non-compliance with minimum bid price ($1.00) and stockholders' equity ($2.5M) requirements.","Company will not appeal; common stock will be suspended from Nasdaq at open on May 9, 2024.","Shares expected to trade on OTC Pink Sheets; no assurance of market development.","Previously received compliance periods ending April 29, 2024, but failed to regain compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-020272","json":"https://secwatch.observer/filing/0001628280-24-020272.json","markdown":"https://secwatch.observer/filing/0001628280-24-020272.md","text":"https://secwatch.observer/filing/0001628280-24-020272.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1522860/000162828024020272/0001628280-24-020272-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1522860/000162828024020272/afib-20240430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T23:08:04.584112+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"aae8c6878a6dad0e319e22d6b4df8a6cec4eabdb","claim":"Acutus Medical, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b), 5810(d)(2)).","evidence_excerpt":"April 30, 2024, the Staff notified the Company that it has not regained compliance with Listing Rule 5550(a)(2). The Staff also notified the Company, as a separate basis for delisting pursuant to Listing Rule 5810(d)(2), that the Company is not in compliance with Listing Rule 5550(b) for failure to maintain stockholders’ equity of at least $2.5 million, or either of the alternatives to compliance with this standard ((i) market value of listed securities of $35 million or (ii) net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last thre","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1522860/000162828024020272/0001628280-24-020272-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b), 5810(d)(2)"}],"fact_type":"exchange_compliance_notice"},{"claim_id":"d186dedefc91da4da70dc6c5742287c7039e0a6e","claim":"Acutus Medical, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A), 5550(a)(2), 5810(d)(2), 5550(b)).","evidence_excerpt":"April 30, 2024, the Staff notified the Company that it has not regained compliance with Listing Rule 5550(a)(2). The Staff also notified the Company, as a separate basis for delisting pursuant to Listing Rule 5810(d)(2), that the Company is not in compliance with Listing Rule 5550(b) for failure to maintain stockholders’ equity of at least $2.5 million, or either of the alternatives to compliance with this standard ((i) market value of listed securities of $35 million or (ii) net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last thre","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1522860/000162828024020272/0001628280-24-020272-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5450(a)(1), 5810(c)(3)(A), 5550(a)(2), 5810(d)(2), 5550(b)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}